GLP-1 RECEPTOR AGONIST EFFECT ON RETAINED GASTRIC CONTENTS ON EGD: A QUALITY IMPROVEMENT STUDY

被引：0
|
作者：
Hernandez, Luis [1 ]
Ukwade, Dirin [1 ]
Modi, Zeel [1 ]
Raza, Hasan [1 ]
Siegel, Michael [1 ]
Nwachukwu, Dexter [1 ]
Sarraf, Paya [1 ]
Booth, Marya [1 ]
Cooper-Washington, Karen [1 ]
Boulay, Brian [1 ]
Mutlu, Ece [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
GASTROINTESTINAL ENDOSCOPY | 2024年 / 99卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1091
引用
收藏
页码：AB382 / AB382
页数：1
相关论文
共 50 条
  • [21] Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist
    Young, Malcolm A.
    Wald, Jeffrey A.
    Matthews, Jessica E.
    Scott, Rhona
    Hodge, Rebecca J.
    Zhi, Hui
    Reinhardt, Rickey R.
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 84 - 97
  • [22] Effect of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids
    Suschak, John J.
    Georges, Bertrand
    Roberts, M. S.
    Harris, M. Scott
    Browne, Sarah K.
    DIABETES, 2024, 73
  • [23] The Impact of GLP-1 Receptor Agonists on Retained Gastric Contents, Aborted Procedures, and Aspiration During Esophagogastroduodenoscopy: A Systematic Review and Meta-Analysis
    Montalvan-Sanchez, Eleazar Enrique.
    Norwood, Dalton A.
    Beas, Renato
    Chapman, Malcolm B.
    Montalvan-Sanchez, Daniela M.
    Sierra, Leandro
    Ramirez, Mirian
    Sanchez-Luna, Sergio A.
    Peter, Shajan
    Morgan, Douglas
    Mulki, Ramzi
    Dougherty, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S):
  • [24] Impact of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Use on Retained Gastric Contents and Adverse Events With Upper Endoscopy: A Systematic Review and Meta-Analysis
    Rahman, Syed Hamaad
    Khan, Nihal I.
    Farooq, Aimen
    Shafique, Nouman
    Qureshi, Mahir
    Mohamed, Islam
    Musallam, Rami
    Hurairah, Abu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S):
  • [25] Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying - preclinical evidence
    Werner, Ulrich
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (01) : 110 - 114
  • [26] Impact of GLP-1 Receptor Agonist Indication on Gastric Retention and Boston Bowel Preparatory Score
    DiMarino, Michael J.
    Patel, Akash
    Torre, Beatriz
    Young, Benjamin
    Duffey, Katherine
    Noverati, Nicholas
    Kistler, Charles
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S598 - S598
  • [27] Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD
    Chapman, Malcolm B.
    Norwood, Dalton A.
    Price, Christopher
    Abdulhadi, Basma
    Baig, Kondal Kyanam Kabir
    Ahmed, Ali M.
    Peter, Shajan
    Routman, Justin S.
    Sanchez-Luna, Sergio A.
    Duggan, Elizabeth W.
    Mulki, Ramzi
    GASTROINTESTINAL ENDOSCOPY, 2024, 100 (05) : 923 - 927
  • [28] Effect of the GLP-1 Agonist Lixisenatide on the Pharmacokinetics of Warfarin
    Liu, Yan-Hong
    Ruus, Peter
    Steinstraesser, Axel
    Teichert, Lenore
    DIABETES, 2010, 59 : A558 - A558
  • [29] A Novel Antihypertensive Effect of Exenatide, a GLP-1 Agonist
    Dandona, Paresh
    Chaudhuri, Ajay
    Dhindsa, Sandip
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (03) : 228 - 228
  • [30] Liraglutide, GLP-1 receptor agonist, for chronic weight loss
    Moore, Katherine G.
    Shealy, Kayce
    Clements, Jennifer N.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 373 - 378
12345